Emerald Advisers’s Supernus Pharmaceuticals SUPN Stock Holding History

Emerald Advisers’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$10.6M	Buy
2022 Q2	$2.02M	Buy
2018 Q1	–	Sell
2017 Q4	$22M	Sell
2017 Q3	$24.2M	Buy
2017 Q2	$21.5M	Buy